March 13, 2024
3 min watch
Save
VIDEO: JAK inhibitors usher new era in alopecia areata treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN DIEGO — In this Healio video perspective here at the American Academy of Dermatology, Brett King, MD, PhD, FAAD, discusses how new Janus kinase inhibitors have changed the paradigm of alopecia areata treatment.
“We’ve come in a very short period of time from having absolutely nothing to this sort of revolution that [Janus kinase (JAK)] inhibitors have brought to dermatologists and our patients,” King said.
King, associate professor of dermatology at Yale School of Medicine, discusses the latest research being presented during the meeting showing the long-term safety and efficacy of JAK inhibitors for the treatment of alopecia areata.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
King reports consulting widely in the field of dermatology, including for Eli Lilly, Pfizer and Sun Pharma.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.